Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ardelyx, Inc. - Common Stock
(NQ:
ARDX
)
5.900
-0.020 (-0.34%)
Streaming Delayed Price
Updated: 9:36 AM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ardelyx, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
March 13, 2025
Award established to recognize leaders in the field of chronic kidney disease advocacy
From
Ardelyx, Inc.
Via
GlobeNewswire
Tenapanor Approved in China for Hyperphosphatemia
February 26, 2025
Ardelyx to receive $5 million milestone payment from Fosun Pharma following approval
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx to Participate in Upcoming Investor Conferences
February 25, 2025
From
Ardelyx, Inc.
Via
GlobeNewswire
Breaking Down Ardelyx: 4 Analysts Share Their Views
↗
February 21, 2025
Via
Benzinga
Earnings Scheduled For February 20, 2025
↗
February 20, 2025
Via
Benzinga
What Analysts Are Saying About Ardelyx Stock
↗
January 27, 2025
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Ardelyx Stock
↗
January 02, 2025
Via
Benzinga
Ardelyx Stock Rises After-Hours On Q4 Beat, Drug Sales Outlook: Retail Gets Big Dose Of Optimism
↗
February 20, 2025
Revenue for the quarter was $116.13 million, topping the consensus estimate of $111.16 million, driven by robust sales of its two approved drugs, Ibsrela and Xphozah.
Via
Stocktwits
Ardelyx Tops Estimates as Sales Surge
↗
February 20, 2025
The biopharma reported strong revenue growth in the fourth quarter thanks to solid performances from both of its approved products, Ibsrela and Xphozah.
Via
The Motley Fool
Palantir Rally Loses Steam, Walmart Outlook Disappoints: What's Driving Markets Thursday?
↗
February 20, 2025
Stocks tumbled Thursday, with all major indices in the red, one day after the S&P 500 notched another all-time high in Wednesday’s trading session.
Via
Benzinga
Ardelyx Beats Q3 Sales Estimates, Shares Climb
↗
October 31, 2024
Ardelyx reported its third-quarter results after Thursday's closing bell. Here's a look at the details from the report:
Via
Benzinga
Ardelyx's Earnings Outlook
↗
October 30, 2024
Via
Benzinga
Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 20, 2025
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference
February 19, 2025
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025
January 30, 2025
Conference call scheduled for 8:00 a.m. Eastern Time
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities
January 13, 2025
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
November 20, 2024
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
November 08, 2024
Inclusion of oral-only phosphate-lowering therapies in the ESRD PPS will put dialysis patients’ health at risk
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
November 05, 2024
From
Ardelyx, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 31, 2024
Via
Benzinga
Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
October 31, 2024
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting
October 28, 2024
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week
October 24, 2024
From
Ardelyx, Inc.
Via
GlobeNewswire
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
October 22, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community
October 22, 2024
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community
October 21, 2024
Deadline to submit nominations is January 31, 2025
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024
October 17, 2024
Conference call scheduled for 4:30 p.m. Eastern Time
From
Ardelyx, Inc.
Via
GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx
October 15, 2024
From
Faruqi & Faruqi, LLP
Via
Business Wire
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week
October 15, 2024
From
Ardelyx, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
